Study Exclusion reasons Remarks Reference(s)
Patel, 2020 prospective cohort cancelled by investigator Surgisphere corporation : retracted publication

Patel

 
IDEA, 2020 prospective cohort no control group

Carvallo H medRxiv https://doi.org/10.1101/2020.09.10.20191619

 
Morgenstern, 2020 single-arm no control group

Morgenstern J medRxiv https://doi.org/10.1101/2020.10.29.20222505

 
Million, 2020 single-arm no control group

Million Travel Med Infect Dis 2020; :101738 10.1016/j.tmaid.2020.101738

 
Chamie-Quintero,, 2020 population based cohort retrospective no control group No statistical analyses just a comparison of death between several peruvian states with or without mass distribution of ivermectin

Chamie-Quintero, J Open Science Foundation

 
Delliere, 2020 retrospective cohort no clinically relevant endpoint The main objective of this study was to determine invasive pulmonary aspergillosis (IPA) incidence in the COVID-19 patients admitted to the intensive care unit (ICU), describe the patient characteristics associated with its occurrence and evaluate the impact on prognosis.

Delliere S et al. Clinical Microbiology and Infection 10.1016/j.cmi.2020.12.005

 
Alberici, 2020 retrospective cohort other HCQ efficacy or safety evaluation wasn't a prespecified endpoint

Alberici F Kidney Int 2020 Jul;98(1):20-26. 10.1016/j.kint.2020.04.030

 
Guerin, 2020 non randomized controlled trial other no binary endpoints

Guérin, Preprints 2020, 2020050486 (doi: 10.20944/preprints202005.0486.v1).

 
Guerin, 2020 non randomized controlled trial other no binary endpoints

Guérin, Preprints 2020, 2020050486 (doi: 10.20944/preprints202005.0486.v1).